International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Fosfomycin: an old, new friend?

(2009) M. Popovic et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use

(2009) M. Sundqvist et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of Fluoroquinolone Resistance in Outpatient Urinary Escherichia coli Isolates

(2008) Luke Johnson et al.   AMERICAN JOURNAL OF MEDICINE

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Prevalence and Risk Factor Analysis of Trimethoprim‐Sulfamethoxazole– and Fluoroquinolone‐ResistantEscherichia coliInfection among Emergency Department Patients with Pyelonephritis

(2008) David A. Talan et al.   CLINICAL INFECTIOUS DISEASES

Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy

(2008) Kurt G. Naber et al.   EUROPEAN UROLOGY

A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis

(2008) Janet Peterson et al.   UROLOGY